Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely ...

A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate cancer on MRI scans. Following the practice-changing UCL-led PROMIS and ...

Philips has integrated animated Disney characters and stories into MRI machines to make imaging scans more comforting and engaging for children. Through the Philips Ambient Experience, the medtech ...

A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use of the test to determine the need for repeat "monitoring" biopsies ...

Radium-223 retains a role in osteoblastic bone-only disease, while PSMA PET has become indispensable across staging, recurrence detection, and patient selection for radioligand therapy. Oliver Sartor, ...

Blender is shaping modern creative pipelines as 3D animation software becomes faster and more specialized. In 2026, many tools deliver stronger viewport performance optimization, handling massive ...

Extraprostatic extension or seminal vesicle invasion detected on preoperative MRI were independently associated with biochemical recurrence and metastatic failure after radical prostatectomy even ...

Claude Code and Nano Banana 2 are platforms designed to support website design by combining functionality and ease of use. As explored by Jack Roberts, these platforms offer features like responsive ...

Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...

Please provide your email address to receive an email when new articles are posted on . Staging from prostate-specific membrane androgen PET/CT had a significant association with PFS. Whole pelvis ...

March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' (LNTH.O), opens new tab prostate cancer imaging agent, aimed at improving ‌scanning ...